COMMUNIQUÉS West-GlobeNewswire

Clearside Biomedical’s Phase 1/2 Open Label Clinical Trial of CLS-TA With and Without Eylea in Diabetic Macular Edema Presented at the American Academy of Ophthalmology 2017 Annual Meeting

13/11/2017 - 13:30

ALPHARETTA, Ga., Nov. 13, 2017 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (NASDAQ: CLSD ), a late-stage clinical biopharmaceutical company developing first-in-class drug therapies to treat back-of-the-eye diseases, [...]

Neuralstem Reports Third Quarter 2017 Fiscal Results and Provides Clinical and Business Update

13/11/2017 - 13:30

GERMANTOWN, Md., Nov. 13, 2017 (GLOBE NEWSWIRE) -- Neuralstem, Inc. (NASDAQ: CUR ), a biopharmaceutical company focused on the development of nervous system therapies based on its neural stem cell technology, reported [...]

RedHill Biopharma Reports 2017 Third Quarter Financial Results

13/11/2017 - 13:30

RedHill maintains a debt-free balance sheet with $39.6 million in cash 1 at the end of the third quarter of 2017 In addition, an underwritten public offering of the Company’s American Depositary Shares (ADSs) is [...]

Society for Immunotherapy of Cancer (SITC) Recognizes Immunovaccine Researchers with Journal for ImmunoTherapy of Cancer (JITC) “Best Basic Science Paper Award”

13/11/2017 - 13:05

HALIFAX, Nova Scotia, Nov. 13, 2017 (GLOBE NEWSWIRE) -- Immunovaccine Inc. (TSX: IMV ) (OTCQX:IMMVF), a clinical stage immuno-oncology company, today announced that the Society for Immunotherapy of Cancer (SITC) has [...]

FDA Clears World’s First and Only Wire-Free Radar Breast Tumor Localization System for Long Term Implant Capabilities

13/11/2017 - 13:00

ALISO VIEJO, Calif., Nov. 13, 2017 (GLOBE NEWSWIRE) -- Cianna Medical, Inc. has received FDA clearance of the SAVI SCOUT® reflector for long term implant. The SAVI SCOUT reflector is an integral part of the SCOUT system [...]

Leap Therapeutics Reports Third Quarter 2017 Financial Results and Announces First Patient Dosed with DKN-01 and KEYTRUDA® (pembrolizumab) in Esophagogastric Cancer Trial

13/11/2017 - 13:00

CAMBRIDGE, Mass., Nov. 13, 2017 (GLOBE NEWSWIRE) -- Leap Therapeutics, Inc. (Nasdaq: LPTX ), a biotechnology company developing targeted and immuno-oncology therapeutics, today reported financial results for the third [...]

Melinta Therapeutics Reports First Patient Treated in Phase 2 Study of Topical Radezolid for Treatment of Acne

13/11/2017 - 13:00

NEW HAVEN, Conn., Nov. 13, 2017 (GLOBE NEWSWIRE) -- Melinta Therapeutics , Inc. (NASDAQ: MLNT ) a commercial-stage company developing and commercializing novel antibiotics to treat serious bacterial infections, [...]

ProQR Doses First LCA 10 Patient in Clinical Trial of QR-110, ProQR’s Lead Program for Genetic Blindness

13/11/2017 - 13:00

Key Updates The first patient has received the first dose of QR-110 in the Phase 1/2 safety & efficacy clinical trial (PQ-110-001: NCT03140969 ) in children and adults with Leber’s congenital amaurosis 10 (LCA 10). [...]

Spero Therapeutics Announces Underwriters’ Option Exercise

13/11/2017 - 13:00

CAMBRIDGE, Mass., Nov. 13, 2017 (GLOBE NEWSWIRE) -- Spero Therapeutics, Inc. (Nasdaq: SPRO ), a multi-asset, clinical-stage biopharmaceutical company focused on identifying, developing and commercializing novel [...]

Protalix BioTherapeutics Receives Positive Opinion for Orphan Designation for PRX-102 for the Treatment of Fabry Disease in the European Union

13/11/2017 - 13:00

CARMIEL, Israel, Nov. 13, 2017 (GLOBE NEWSWIRE) -- Protalix BioTherapeutics, Inc. (NYSE American:PLX) (TASE: PLX ), a biopharmaceutical company focused on the development and commercialization of recombinant therapeutic [...]

AC Immune SA Reports Third Quarter 2017 Financial Results and Corporate Update

13/11/2017 - 12:48

Expansion of pipeline with two new antibodies against proteins alpha-synuclein and TDP-43 Recruitment of first cohort completed for anti-beta vaccine targeting Alzheimer's symptoms in adults with Down syndrome Strong [...]

Jounce Therapeutics Reports Third Quarter 2017 Financial Results

13/11/2017 - 12:30

- Remain on track to announce preliminary efficacy data for the Phase 1/2 ICONIC study in 1H 2018 - - Strengthen leadership team and board with key new appointments - - Update full year financial guidance - - Company to [...]

Kamada Reports Financial Results for Third Quarter and First Nine Months of 2017

13/11/2017 - 12:30

Total Revenues for Third Quarter were $22.9 million, an 18% Increase Total revenues for first 9 months of 2017 were $67.1 million, a 26% Increase On Track to Achieve $100 Million in Total Revenues in 2017 Guiding to $ [...]

Real-World Data Analysis Shows That High Triglyceride Levels Are Associated With Increased Cardiovascular Events and Medical Costs

13/11/2017 - 12:00

Higher Rates of Myocardial Infarction (Heart Attack) and Revascularization Procedures in Patients with High Triglycerides Were Drivers of the Composite Outcome MACE Rate 35% Higher in Patients Who, Despite Statin [...]

Fennec Provides Business Update And Reports Third Quarter 2017 Results

13/11/2017 - 12:00

During the third quarter, the Company announced positive results from its Phase 3 SIOPEL 6 Study Study met primary endpoint (p=0.0033) indicating a significant reduction in cisplatin induced hearing loss without any [...]

Notice of Annual General Meeting

13/11/2017 - 11:37

Please see enclosed pdf.

Anthem Inc. Issues Positive Coverage Decision for Balloon Sinus Dilation

13/11/2017 - 11:30

PLYMOUTH, Minn., Nov. 13, 2017 (GLOBE NEWSWIRE) -- Entellus Medical, Inc. (NASDAQ: ENTL ), a medical technology company focused on delivering minimally invasive ENT procedures, today announced that Anthem, Inc. now [...]

CRISPR Therapeutics and Casebia Collaborate with CureVac on mRNA for Gene-Editing Programs

13/11/2017 - 11:00

ZUG, Switzerland and CAMBRIDGE, Mass. and TÜBINGEN, Germany, and BOSTON, Nov. 13, 2017 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (NASDAQ: CRSP ), a genome editing company focused on creating transformative gene-based [...]

Veritas and Cannevert Hires the Essèntium Group as Their Agent in Puerto Rico USA

13/11/2017 - 09:05

VANCOUVER, British Columbia, Nov. 13, 2017 (GLOBE NEWSWIRE) -- Veritas Pharma Inc. (CSE:VRT) (OTC:VRTHF) (Frankfurt: 2VP ), (“Veritas” or the “Company”) announces that the Company through its research arm, Cannevert [...]